Internal Medicine, Infectious Disease · Middletown, NY
NPI
1255509006
Since 2008
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
155 Crystal Run Rd
Middletown, NY, 10941
Phone (845) 703-6999
Groups this clinician bills Medicare through
Medicare paid, 2024
$165K
2,958 services
Medicare patients, 2024
482
Average age 73
Drug cost, 2024
$1.3M
885 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Malloy Nair was code 99232 (hospital e&m - subsequent), 899 times for 252 patients. In total Malloy Nair billed 2,958 services in 45 codes, and Medicare paid $165K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-10-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 899 | 252 | $66.04 | $59K |
| 99233 Hospital E&M - Subsequent | Facility | 212 | 116 | $99.01 | $21K |
| 99222 Hospital E&M - Initial | Facility | 192 | 164 | $106.72 | $20K |
| 99214 Office E&M - Established | Office | 146 | 83 | $95.65 | $14K |
| 99223 Hospital E&M - Initial | Facility | 103 | 96 | $143.68 | $15K |
| 99213 Office E&M - Established | Office | 67 | 52 | $62.72 | $4,203 |
| 36415 Venipuncture Blood Collection | Office | 59 | 43 | $8.65 | $510 |
| 87077 Bacterial Culture | Office | 49 | 12 | $7.92 | $388 |
| 99204 Office E&M - New | Office | 39 | 39 | $136.38 | $5,319 |
| 80053 Clinical Chemistry | Office | 30 | 24 | $10.35 | $311 |
| 85025 Blood Count | Office | 29 | 22 | $7.61 | $221 |
| 87086 Bacterial Culture | Office | 29 | 13 | $7.91 | $229 |
| 81003 Clinical Chemistry | Office | 24 | 13 | $2.20 | $52.8 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 22 | 16 | $10.71 | $236 |
| 99215 Office E&M - Established | Office | 21 | 21 | $149.75 | $3,145 |
By year: 2022 $135K for 2,001 services; 2023 $141K for 2,025 services; 2024 $165K for 2,958 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 59 | 43 | $8.65 | $510 |
| 87077 Bacterial Culture | 49 | 12 | $7.92 | $388 |
| 80053 Clinical Chemistry | 30 | 24 | $10.35 | $311 |
| 85025 Blood Count | 29 | 22 | $7.61 | $221 |
| 87086 Bacterial Culture | 29 | 13 | $7.91 | $229 |
| 81003 Clinical Chemistry | 24 | 13 | $2.20 | $52.8 |
Medicare prescription drug claims, 2024
In 2024, the drug Malloy Nair prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 114 prescriptions and refills. In total Malloy Nair wrote 885 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 114 | 114 | 11 | $461K |
| Doxycycline Monohydrate Generic | 52 | 60 | 15 | $1,555 |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 52 | 64 | Under 11 | $253K |
| Vancomycin Hcl Generic | 42 | 46 | 14 | $29K |
| Cefuroxime Cefuroxime Axetil | 39 | 41 | 12 | $1,847 |
| Valacyclovir Valacyclovir Hcl | 36 | 45 | Under 11 | $1,113 |
| Emtricitabine-Tenofovir Disop Emtricitabine/Tenofovir (Tdf) | 36 | 38 | Under 11 | $14K |
| Cephalexin Generic | 34 | 52 | Under 11 | $1,967 |
| Doxycycline Hyclate Generic | 33 | 33 | 12 | $702 |
| Ritonavir Generic | 29 | 29 | Under 11 | $2,504 |
| Darunavir Generic | 28 | 28 | Under 11 | $16K |
| Juluca Dolutegravir/Rilpivirine | 26 | 26 | Under 11 | $97K |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 25 | 25 | 11 | $416 |
| Methenamine Hippurate Generic | 24 | 28 | Under 11 | $1,520 |
| Complera Emtricita/Rilpivirine/Tenof Df | 23 | 23 | Under 11 | $89K |
Brand drugs: - claims; generic drugs: 527 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Malloy Nair were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.